Reference
- Killeen T, Kermer V, Troxler Saxer RmRNA vaccine development during the COVID-19 pandemic: a retrospective review from the perspective of the Swiss affiliate of a global biopharmaceutical companyJ Pharm Policy Pract202316158 10.1186/s40545-023-00652-y 38012751 10683226